etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry Archives

Home Tags Etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry

William Leonard Pickard participating in celebration for Sasha Shulgin’s new book...

Psychedelic Science 101: What are Psychedelic Drugs?

Pα+ Psychedelic Bulletin #169: Brin Backs Soneira, But Patent Questions Loom...

Psychedelics in Palliative Care: Screening, Safety Measures, and Experiences With the...

When Data Meets Doubt: Investigating the FDA Panel’s Rejection of MDMA

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Tag: etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry